Abstract
The clinical demand for human mesenchymal stem/stromal cells (MSC) drives the need for reproducible, cost-effective, and good manufacturing practices (GMP)-compliant ex vivo expansion protocols. Bioprocess engineering strategies, namely controlled stirred bioreactor systems combined with the use of xenogeneic(xeno)-free materials, provide proper tools to develop and optimize cell manufacturing for the rapid expansion of human MSC for cellular therapies. Herein we describe a microcarrier-based stirred culture system operating under xeno-free conditions using a controlled stirred-tank bioreactor for an efficient and controlled ex vivo expansion of human MSC. This culture platform can be applied to MSC from different human sources, as well as different microcarriers and xeno-free medium formulations.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Kirouac DC, Zandstra PW (2008) The systematic production of cells for cell therapies. Cell Stem Cell 3:369–381
Kehoe DE, Jing D, Lock LT et al (2010) Scalable stirred-suspension bioreactor culture. Tissue Eng Part A 16:405–421
Rodrigues CAV, Fernandes TG, Diogo MM et al (2011) Stem cell cultivation in bioreactors. Biotechnol Adv 29:815–829
Klingemann H, Matzilevich D, Marchand J (2008) Mesenchymal stem cells—sources and clinical applications. Transfus Med Hemother 35:272–277
Singer NG, Caplan AI (2011) Mesenchymal stem cells: mechanisms of inflammation. Annu Rev Pathol 6:457–478
Atoui R, Chiu RCJ (2012) Concise review: immunomodulatory properties of mesenchymal stem cells in cellular transplantation : update, controversies, and unknowns. Stem Cells Transl Med 1:200–205
Dittmar T, Entschladen F (2013) Migratory properties of mesenchymal stem cells. Adv Biochem Eng Biotechnol 129:117–136
Parekkadan B, Milwid JM (2010) Mesenchymal stem cells as therapeutics. Annu Rev Biomed Eng 12:87–117
Tarte K, Gaillard J, Lataillade J et al (2010) Clinical-grade production of human mesenchymal stromal cells: occurrence of aneuploidy without transformation. Blood 115:1549–1553
Migliaccio G, Pintus C (2012) Role of the EU framework in regulation of stem cell-based products. Adv Biochem Eng Biotechnol 30:287–299. doi:10.1007/10_2012_142
Eibes G, dos Santos F, Andrade PZ et al (2010) Maximizing the ex vivo expansion of human mesenchymal stem cells using a microcarrier-based stirred culture system. J Biotechnol 146:194–197
dos Santos F, Andrade PZ, Abecasis MM et al (2011) Toward a clinical-grade expansion of mesenchymal stem cells from human sources: a microcarrier-based culture system under xeno-free conditions. Tissue Eng Part C Methods 17:1201–1210
Schop D, Borgart E, Janssen FW et al (2010) Expansion of human mesenchymal stromal cells on microcarriers: growth and metabolism. J Tissue Eng Regen Med 4:131–140
Yuan Y, Kallos MS, Hunter C et al (2012) Improved expansion of human bone marrow-derived mesenchymal stem cells in microcarrier-based suspension culture. J Tissue Eng Regen Med 8:210–225. doi:10.1002/term.1515
Hewitt CJ, Lee K, Nienow AW et al (2011) Expansion of human mesenchymal stem cells on microcarriers. Biotechnol Lett 33:2325–2335
Miwa H, Hashimoto Y, Tensho K et al (2012) Xeno-free proliferation of human bone marrow mesenchymal stem cells. Cytotechnology 64:301–308
Kinzebach S, Bieback K (2012) Expansion of mesenchymal stem/stromal cells under xenogenic-free culture conditions. Adv Biochem Eng Biotechnol 129:33–57. doi:10.1007/10_2012_134
Lindroos B, Boucher S, Chase L et al (2009) Serum-free, xeno-free culture media maintain the proliferation rate and multipotentiality of adipose stem cells in vitro. Cytotherapy 11:958–972
Jung S, Sen A, Rosenberg L et al (2010) Identification of growth and attachment factors for the serum-free isolation and expansion of human mesenchymal stromal cells. Cytotherapy 12:637–657
dos Santos F, Campbell A, Fernandes-Platzgummer A et al (2014) A xenogeneic-free bioreactor system for the clinical-scale expansion of human mesenchymal stem/stromal cells. Biotechnol Bioeng 111:1116–1127. doi:10.1002/bit.25187
Dominici M, Le Blanc K, Mueller I et al (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement. Cytotherapy 8:315–317
Carmelo JG (2013) Optimizing the production of human mesenchymal stem/stromal cells in xeno-free microcarrier-based reactor systems. MSc Dissertation, Instituto Superior Técnico, Universidade de Lisboa, Lisboa
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this protocol
Cite this protocol
Carmelo, J.G., Fernandes-Platzgummer, A., Cabral, J.M.S., da Silva, C.L. (2014). Scalable Ex Vivo Expansion of Human Mesenchymal Stem/Stromal Cells in Microcarrier-Based Stirred Culture Systems. In: Turksen, K. (eds) Stem Cells and Good Manufacturing Practices. Methods in Molecular Biology, vol 1283. Humana Press, New York, NY. https://doi.org/10.1007/7651_2014_100
Download citation
DOI: https://doi.org/10.1007/7651_2014_100
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-2434-9
Online ISBN: 978-1-4939-2435-6
eBook Packages: Springer Protocols